Safety, Immunogenicity and Efficacy of the Pfizer Vaccine Amongst 686 Patients with Autoimmune Inflammatory Rheumatic Diseases
Israel has been a model for vaccination success against COVID-19, with over 56% of the country being fully vaccinated. On Monday, June 13, Israeli researchers published the findings of the largest observational prospective study confirming the immunogenicity, efficacy, and safety of the Pfizer vaccine amongst 686 patients with autoimmune inflammatory rheumatic diseases (AIIRD).
Read More »